Cover Image

Sex Differences in Response to TNF-Inhibiting Drugs in Patients With Spondyloarthropathies or Inflammatory Bowel Diseases

Spondyloarthritis (SpA) and inflammatory bowel diseases (IBD) are chronic inflammatory diseases characterized by an aberrant immune response and inflammation with a key role for TNF in their pathogenesis. Accordingly, TNF-inhibiting therapy (TNFi) has dramatically improved the management of these di...

Full description

Saved in:

Bibliographic Details
Main Authors:	Bruno Laganà (Author), Angelo Zullo (Author), Maria Lia Scribano (Author), Maria Sole Chimenti (Author), Alberto Migliore (Author), Andrea Picchianti Diamanti (Author), Roberto Lorenzetti (Author), Palma Scolieri (Author), Lorenzo Ridola (Author), Elena Ortona (Author), Marina Pierdominici (Author), Vincenzo Bruzzese (Author)
Format:	Book
Published:	Frontiers Media S.A., 2019-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Anti-tumor necrosis factor α: originators <i>versus</i> biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies
by: C. Gioia, et al.
Published: (2023)

Seronegative spondyloarthropathies and allergic diseases in patients with ulcerative colitis
by: F. Manguso, et al.
Published: (2002)

Role of Interleukin- (IL-) 17 in the Pathogenesis and Targeted Therapies in Spondyloarthropathies
by: I-Tsu Chyuan, et al.
Published: (2018)

The therapeutic value of low-energy laser (LLLT) for enthesitis in children with juvenile spondyloarthropathies
by: Harjacek M, et al.
Published: (2008)

Identifying circRNA-associated-ceRNA networks in juvenile spondyloarthropathies patients
by: Wei Qijiao, et al.
Published: (2023)

The role of interleukin-17 in spondyloarthropathies and systemic lupus erythematosus: Two clinical cases in real
by: Paula Antunes, et al.
Published: (2022)

Patients with enthesitis related arthritis show similar monocyte function pattern as seen in adult axial spondyloarthropathy
by: Shruti Bhattacharya, et al.
Published: (2020)

Efficacy of gluten-free diet in patients with rheumatoid arthritis
by: V. Bruzzese, et al.
Published: (2021)

Biclonal gammopathy of undetermined significance in a patient with systemic lupus erythematosus and antiphospholipid syndrome
by: V. Bruzzese, et al.
Published: (2022)

Seronegative spondyloarthropathy-related sacroiliitis: Differencial diagnosis between infectious sacroiliitis and spondyloarthritis, where the inflammation in the sacroiliac joint starts
by: Dejan Spasovski
Published: (2020)

The Mediterranean Fever Gene Mutations and Its Association with HRQoL, Depression and Fatigue in Patients with Familial Mediterranean Fever Associated Spondyloarthropathies
by: Sevgi Gümüş Atalay, et al.
Published: (2022)

Psoriatic spondyloarthritis and Sjögren syndrome: a casual association?
by: V. Bruzzese, et al.
Published: (2020)

Efficacy of a gluten-free diet in reducing the widespread pain index and symptom severity scale in patients affected by fibromyalgia
by: V. Bruzzese, et al.
Published: (2023)

TNF Blocking Therapies and Immunomonitoring in Patients with Inflammatory Bowel Disease
by: Romain Altwegg, et al.
Published: (2014)

Anti-TNFα in inflammatory bowel disease: from originators to biosimilars
by: Zhen Zeng, et al.
Published: (2024)

Carotid intima media thickness in patients with lupus nephritis: some appraisals
by: V. Bruzzese, et al.
Published: (2013)

Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease
by: Sara Salvador-Martín, et al.
Published: (2021)

Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
by: Paula Zapata-Cobo, et al.
Published: (2023)

Anti-TNF-α Therapy Suppresses Proinflammatory Activities of Mucosal Neutrophils in Inflammatory Bowel Disease
by: Cui Zhang, et al.
Published: (2018)

Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
by: Paula Zapata-Cobo, et al.
Published: (2023)

Effect of Therapeutic Inhibition of TNF on Circulating Endothelial Progenitor Cells in Patients with Rheumatoid Arthritis
by: F. R. Spinelli, et al.
Published: (2013)

Cost-Effectiveness of Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease: A Systematic Review
by: Silvia Marquez-Megias, et al.
Published: (2022)

A minimal physiologically based pharmacokinetic model to characterize colon TNF suppression and treatment effects of an anti-TNF monoclonal antibody in a mouse inflammatory bowel disease model
by: Songmao Zheng, et al.
Published: (2020)

Comment: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
by: Chin-Yuan Yii, et al.
Published: (2023)

Different effects of anti-TNF-alpha biologic drugs on the small bowel macroscopic inflammation in patients with ankylosing spondylitis
by: Chitul A., et al.
Published: (2017)

Anaphylactic shock with methylprednisolone sodium succinate in a child with short bowel syndrome and cow's milk allergy
by: Federica Porcaro, et al.
Published: (2017)

Pattern and Severity of Psoriasiform Eruptions in Patients with Inflammatory Bowel Diseases, Arthritis or Skin Inflammatory Disorders Treated with TNF-alpha Inhibitors
by: Anne-Sophie Darrigade, et al.
Published: (2017)

Antibiotics influence the risk of anti-drug antibody formation during anti-TNF therapy in Chinese inflammatory bowel disease patients
by: Meng Sun, et al.
Published: (2024)

Noncanonical NF-κB Signaling Upregulation in Inflammatory Bowel Disease Patients is Associated With Loss of Response to Anti-TNF Agents
by: Vu Q. Nguyen, et al.
Published: (2021)

Anti-TNF-α Monoclonal Antibody Therapy Improves Anemia through Downregulating Hepatocyte Hepcidin Expression in Inflammatory Bowel Disease
by: Weigang Shu, et al.
Published: (2019)

Radioimmune Imaging of α<sub>4</sub>β<sub>7</sub> Integrin and TNFα for Diagnostic and Therapeutic Applications in Inflammatory Bowel Disease
by: Alberto Signore, et al.
Published: (2023)

Systematic review of TNFα-induced paradoxical psoriasis: Treatment outcomes of switching to alternative biologic therapies in inflammatory bowel disease patients
by: Rishab Revankar, et al.
Published: (2023)

Tumor necrosis factor alpha (TNFα)-binding imprinted polymers. A non-systemic therapeutic approach for inflammatory bowel diseases
by: Rina Arad Yellin, et al.
Published: (2023)

Treat to target: a winner strategy in rheumatology. From the past to the future
by: Vincenzo Bruner, et al.
Published: (2021)

Sex Differences of Human Cardiac Progenitor Cells in the Biological Response to TNF-α Treatment
by: Elisabetta Straface, et al.
Published: (2017)

Improved diagnosis of inflammatory bowel disease and prediction and monitoring of response to anti-TNF alpha treatment based on measurement of signal transduction pathway activity
by: Wilbert Bouwman, et al.
Published: (2022)

Novel Photoactive Materials
by: Diamanti, Maria Vittoria
Published: (2019)

Corrigendum: Improved diagnosis of inflammatory bowel disease and prediction and monitoring of response to anti-TNF alpha treatment based on measurement of signal transduction pathway activity
by: Wilbert Bouwman, et al.
Published: (2023)

TNF-α and TNF-R-1 level in pregnancy with ecotopic pregnancy
by: Yu. B. Yakymchuk, et al.
Published: (2019)

Significant advantages for first line treatment with TNF-alpha inhibitors in pediatric patients with inflammatory bowel disease - Data from the multicenter CEDATA-GPGE registry study
by: Merle Claßen, et al.
Published: (2022)